JP2007504863A5 - - Google Patents

Download PDF

Info

Publication number
JP2007504863A5
JP2007504863A5 JP2006525566A JP2006525566A JP2007504863A5 JP 2007504863 A5 JP2007504863 A5 JP 2007504863A5 JP 2006525566 A JP2006525566 A JP 2006525566A JP 2006525566 A JP2006525566 A JP 2006525566A JP 2007504863 A5 JP2007504863 A5 JP 2007504863A5
Authority
JP
Japan
Prior art keywords
app
binding
peptide
antibody
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006525566A
Other languages
English (en)
Japanese (ja)
Other versions
JP4509113B2 (ja
JP2007504863A (ja
Filing date
Publication date
Priority claimed from AT0144403A external-priority patent/AT413336B/de
Application filed filed Critical
Publication of JP2007504863A publication Critical patent/JP2007504863A/ja
Publication of JP2007504863A5 publication Critical patent/JP2007504863A5/ja
Application granted granted Critical
Publication of JP4509113B2 publication Critical patent/JP4509113B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006525566A 2003-09-12 2004-09-13 アフェレーシス装置 Expired - Fee Related JP4509113B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0144403A AT413336B (de) 2003-09-12 2003-09-12 Apherese-vorrichtung
PCT/AT2004/000311 WO2005025651A1 (de) 2003-09-12 2004-09-13 Apherese-vorrichtung

Publications (3)

Publication Number Publication Date
JP2007504863A JP2007504863A (ja) 2007-03-08
JP2007504863A5 true JP2007504863A5 (cg-RX-API-DMAC7.html) 2010-03-25
JP4509113B2 JP4509113B2 (ja) 2010-07-21

Family

ID=34280361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006525566A Expired - Fee Related JP4509113B2 (ja) 2003-09-12 2004-09-13 アフェレーシス装置

Country Status (15)

Country Link
US (2) US7935252B2 (cg-RX-API-DMAC7.html)
EP (1) EP1663347B1 (cg-RX-API-DMAC7.html)
JP (1) JP4509113B2 (cg-RX-API-DMAC7.html)
CN (1) CN100556472C (cg-RX-API-DMAC7.html)
AT (2) AT413336B (cg-RX-API-DMAC7.html)
AU (1) AU2004271651B2 (cg-RX-API-DMAC7.html)
CA (1) CA2538305C (cg-RX-API-DMAC7.html)
CY (1) CY1107911T1 (cg-RX-API-DMAC7.html)
DE (1) DE502004005851D1 (cg-RX-API-DMAC7.html)
DK (1) DK1663347T3 (cg-RX-API-DMAC7.html)
ES (1) ES2298789T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20080090T3 (cg-RX-API-DMAC7.html)
PL (1) PL1663347T3 (cg-RX-API-DMAC7.html)
PT (1) PT1663347E (cg-RX-API-DMAC7.html)
WO (1) WO2005025651A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003303198A1 (en) 2002-12-19 2004-07-14 New York University Method for treating amyloid disease
AT500483B1 (de) 2004-07-13 2006-01-15 Mattner Frank Dr Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
AT501621A1 (de) * 2005-03-15 2006-10-15 Mattner Frank Dr Zusammensetzungen zur verwendung bei der vorbeugung und behandlung der alzheimer- erkrankung
ES2332846B1 (es) * 2007-10-26 2010-07-08 Grifols, S.A. Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos.
EP2237804B1 (en) * 2007-12-21 2013-04-10 GE Healthcare Bio-Sciences AB Method for sterilization of chemically activated solid support materials
US20100030196A1 (en) * 2008-07-29 2010-02-04 Medtronic, Inc. Apheresis of a target molecule from cerebrospinal fluid
US20100158893A1 (en) * 2008-12-19 2010-06-24 Baxter International Inc. Systems and methods for obtaining immunoglobulin from blood
CN102264411B (zh) * 2008-12-22 2014-10-22 学校法人藤田学园 Aβ除去材料、Aβ除去器和Aβ除去系统
US20110033463A1 (en) * 2009-08-06 2011-02-10 Medtronic, Inc. Apheresis, administration of agent, or combination thereof
EP2497828A1 (en) * 2011-03-07 2012-09-12 Charité - Universitätsmedizin Berlin Use of aptamers in therapy and/or diagnosis of autoimmune diseases
RS53496B1 (sr) 2011-10-04 2015-02-27 Affiris Ag POSTUPAK ZA DETEKCIJU Aβ-SPECIFIČNIH ANTITELA U BIOLOŠKOM UZORKU
US9717841B2 (en) 2012-09-11 2017-08-01 Gary L. McNeil Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source
EP3166660B1 (en) * 2014-07-10 2017-12-13 Affiris AG Substances and methods for the use in prevention and/or treatment in huntington's disease
JP6876601B2 (ja) 2014-07-10 2021-05-26 アフィリス・アクチェンゲゼルシャフトAffiris Ag ハンチントン病の予防および/または処置における使用のための物質および方法
CN111201030B (zh) 2017-07-25 2024-11-01 真和制药有限公司 通过阻断tim-3和其配体的相互作用治疗癌症
KR20210124308A (ko) 2019-01-30 2021-10-14 트루바인딩 아이엔씨. 항-gal3 항체 및 이의 용도
GB201904810D0 (en) * 2019-04-05 2019-05-22 Cynapsedx Ltd The treatment of protein aggregation diseases
MX2022014786A (es) 2020-05-26 2023-01-16 Truebinding Inc Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3.

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57103649A (en) * 1980-12-18 1982-06-28 Asahi Chemical Ind Sterilized gamma-globulin fixing column
US4770774A (en) * 1985-09-19 1988-09-13 Toray Industries, Inc. Column for removing β2 -microglobulin
DE3880647T2 (de) * 1987-11-20 1993-11-18 Kanegafuchi Chemical Ind Sorbentmittel für Serum-Amyloid-Proteine.
US5216127A (en) * 1987-11-20 1993-06-01 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Adsorbent for serum amyloid protein
JPH01171638A (ja) * 1987-12-25 1989-07-06 Kanegafuchi Chem Ind Co Ltd 血清アミロイドa蛋白用吸着体
US5604102A (en) * 1992-04-15 1997-02-18 Athena Neurosciences, Inc. Methods of screening for β-amyloid peptide production inhibitors
JPH06104122A (ja) 1992-09-21 1994-04-15 Matsushita Electric Ind Co Ltd ロータリートランス
AU691297B2 (en) * 1994-05-13 1998-05-14 Miltenyi Biotec Gmbh Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood
DE19515554C2 (de) * 1995-04-27 1999-06-17 Braun Melsungen Ag Verwendung eines Mittels und Vorrichtung zur simultanen extrakorporalen Elimination von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus Vollblut oder/und Blutplasma
US5868936A (en) * 1996-06-20 1999-02-09 Baxter International Inc. Affinity membrane system and method of using same
US6787523B1 (en) * 1997-12-02 2004-09-07 Neuralab Limited Prevention and treatment of amyloidogenic disease
EA006606B1 (ru) 2000-02-24 2006-02-24 Вашингтон Юниверсити Гуманизированное антитело и его фрагмент, взаимодействующие с бета-амилоидным пептидом, и способы их применения
TWI238251B (en) * 2000-07-13 2005-08-21 Anawrhta Biotech Co Ltd In-vitro adsorbing device using immunity
US20050227941A1 (en) * 2001-12-17 2005-10-13 Karen Duff Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseases
AU2003303198A1 (en) * 2002-12-19 2004-07-14 New York University Method for treating amyloid disease
AT413945B (de) * 2003-01-14 2006-07-15 Mattner Frank Dr Impfstoff für die alzheimer-krankheit
AT413946B (de) * 2004-07-13 2006-07-15 Mattner Frank Dr Impfstoff gegen die alzheimer-krankheit
AT500835B1 (de) * 2004-09-13 2007-12-15 Affiris Forschungs & Entwicklungs Gmbh Cholinestertransport-protein-mimotop als atherosklerose-medikament

Similar Documents

Publication Publication Date Title
JP2008506665A5 (cg-RX-API-DMAC7.html)
US7935348B2 (en) Combination therapy for the treatment of Alzheimer's disease
Zhang et al. Multiple-peptide conjugates for binding β-amyloid plaques of Alzheimer's disease
TR200001795T2 (tr) 1-İkameli-1-Aminometil-sikloalkan türevleri (=Gabapentin analogları), bunların hazırlanması ve nörolojik bozuklukların tedavisinde kullanımı.
ATE430569T1 (de) Neue arzneimittel zur behandlung von chronisch obstruktiver lungenerkrankung
CN101420992B (zh) 用于体外处理含粒子的液体的可再生过滤器及其应用
DE60208366D1 (de) Substituierte azabicyclische einheiten zur krankheitsbehandlung (nikotinische acetylcholinrezeptor-antagonisten)
WO2008050148A3 (en) Therapy for liver disease
CA2538305A1 (en) Apheresis device
Yamamoto et al. Adsorption of protein‐bound uremic toxins through direct hemoperfusion with hexadecyl‐immobilized cellulose beads in patients undergoing hemodialysis
PT1183015E (pt) Pastilha em multicamadas para administracao de uma combinacao fixa de tramadol e diclofenac
DE60142500D1 (de) Humane monoklonale Antikörper gegen das kostimulatorische Signaltransduktionsmolekül AILIM und pharmazeutische Verwendungen davon
RU2018139166A (ru) Полипептиды, селективные к рецепторам глюкагона, и способы их применения
EP2277570A3 (en) Medical devices containing rapamycin analogs
JP2007513079A5 (cg-RX-API-DMAC7.html)
JP2004538477A5 (cg-RX-API-DMAC7.html)
DK2841447T3 (en) Hitherto UNKNOWN COMPOSITION FOR EXTRACORPORAL REDUCTION OF BETA AMYLOIDS AND METHOD FOR PREPARING IT
EE200200199A (et) N-guanidinoalküülamiid, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning raviotstarbeline kasutamine
EE04855B1 (et) Hüübimistegurit pärssiv ühend, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaatning raviotstarbeline kasutamine
EP1491210A4 (en) THERAPEUTIC MEDICAMENT USING ANTIBODY PRESENTING HOLES PROTEIN NANOTEHICLES AND HIGH PROTEIN NANOTEHICLES
FR2819810B1 (fr) Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin
NO20010029D0 (no) Anvendelse av cystein-derivater for fremstilling av en medisin for behandling av patologier som stammer fra dannelse av heterotrimert G-protein
JP6703973B2 (ja) β2mタンパク質の治療的使用
Wolinsky Rational therapy for relapsing multiple sclerosis
WO2005122712A3 (en) Soluble low-density lipoprotein receptor related protein binds directly to alzheimer’s amyloid-beta peptide